Tuesday Pre-Market Top Gainers $OCX $MCEP


News

USA Corona Virus

 

Live Stream

https://youtu.be/C4eeCLvozuM

 

Research / Recap Video

 

10:33AM bah9681Here is another TOS thing that they don't disclose: They run a report on traders that place over 390 trades a day (to include cancelled orders) and will flag you and threaten commissions of $2

 

 

Watchlist

OCX [AMEX]
OncoCyte Corporation
Healthcare | Biotechnology | USA

70% 138mc 57f

Dec-15-20 01:33AM  
Dec-07-20 04:05PM  

 

AVXL [NASD]
Anavex Life Sciences Corp.
Healthcare | Biotechnology | USA

40% 313mc 58f

Dec-15-20 07:00AM  
Nov-30-20 07:00AM  
Nov-27-20 10:00AM  

 

ANCN [NASD]
Anchiano Therapeutics Ltd.
Healthcare | Biotechnology | USA

200% 11mc 3f

Merger brings lead compound CM-101, a first in class anti-CCL24 antibody into advanced clinical development for fibrosis-related diseases with significant unmet medical need

Concurrent PIPE financing to be used to fund clinical trials for CM-101 in fibrotic indications, focusing on two rare diseases and backed by leading healthcare-focused investors OrbiMed and Peter Thiel

CAMBRIDGE, Mass. and TEL-AVIV, Israel, Dec. 15, 2020 (GLOBE NEWSWIRE)

 

 

 


 

Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull

Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save

Watchlist 👉👉 https://tradejournal.co/post/tuesday-pre-market-top-gainers-ocx-mcep/

Table of Contents
  • Loading TOC...

FAQ

The top pre-market gainers include OncoCyte Corporation (OCX), Anavex Life Sciences Corp. (AVXL), and Anchiano Therapeutics Ltd. (ANCN).

OncoCyte Corporation recently announced an exclusive in-licensing of a risk stratification test for early-stage lung cancer patients in China.

Anavex Life Sciences announced that its drug ANAVEX®2-73 (Blarcamesine) met primary and secondary endpoints in a Phase 2 clinical trial for treating adult patients with Rett Syndrome.

Anchiano Therapeutics is advancing its lead compound CM-101, a first-in-class anti-CCL24 antibody, for fibrosis-related diseases with significant unmet medical needs.

You can access the watchlist through the provided link in the blog post.


Back to the post list  ⋅  0 comments have been posted.


Helpful TradeJournal Resources

Learn more about trading journals and how to improve your performance:

What is the Best Trading Journal?

Discover the 3 features that make a trading journal profitable: time savings, AI pattern detection, and free mentorship.

Free Trading Journal Template

Download our free Excel and Google Sheets templates to start journaling today. Perfect for beginners!

Free Pro Trader Call

Get a FREE 20-minute 1-on-1 onboarding call ($300 value) with every TradeJournal subscription.

Sample Toast 11 mins ago
tradejournal test feature